1. Introduction {#sec1}
===============

The combination of a sedentary lifestyle with easy access to processed foods rich in low-quality fats and sugars is largely responsible for the increase in obesity in modern Western culture, among others in Europe ([@bib10]). Metabolic disorders like type 2 diabetes and cardiovascular diseases as well as cancer and immune system dysfunctions have been linked to obesity ([@bib31], [@bib32]). Recently during the pandemic of covid-19 obese individuals, suffering dysmetabolism, seemed to have a more severe evolution and a lower survival rate ([@bib36]; [@bib42]; [@bib47]). Metabolic stress can be exacerbated by the exposure to environmental pollutants and disturbing among others lipid metabolism such as pesticides ([@bib9]), common food additives ([@bib17]), or even near-roadway air pollution ([@bib29]).

The redox status is intimately linked to metabolic status, especially lipid metabolism. This is supported by experiments showing that abnormal lipid metabolism is associated with the activation of oxidative and inflammatory pathways ([@bib61]). This can be due to the modulation of transcription factors such as the nuclear factor-erythroid 2 p45-related factor 2 (NRF2) which is known to coordinate the antioxidant response ([@bib37]), but also the metabolism of lipids including their peroxidation ([@bib20]). In addition, there is a positive correlation between levels of oxidative stress and the atherogenicity of serum cholesterol fractions ([@bib58]). This suggested that the level of oxidative stress is an early event influencing the evolution of dyslipidemia documenting the interplay between oxidative damages, redox and metabolic biomarkers.

There is a need to find natural ways for humans to reduce the prevalence of obesity as well as dysmetabolism in order to improve their metabolic health. In addition, it would be important to improve our oxidative status and strengthen defense mechanisms against various diseases including those caused by viruses like covid-19. A possible approach to achieve these objectives could be long-term fasting, that is defined as voluntary food abstinence from 2 days to several weeks ([@bib55]). The study of various forms of fasting on metabolic health has been gaining ground in recent years with more and more studies showing beneficial effects such as inactivating of the mechanistic target of rapamycin (mTOR) signaling pathways as well as several others resulting in metabolic normalization, enhanced autophagy and apoptosis followed by cell regeneration, increased brain-derived neurotrophic factor (BDNF) levels in brain leading to enhanced cognition, mood as well as increased neuronal plasticity and regeneration. Fasting also enhanced the transcription of cytoprotective enzymes, mitochondrial biogenesis all of these effects leading to restoration and conservation of functional integrity of cells and tissues ([@bib18]; [@bib55]). Moreover, it has been shown that long-term fasting improved dysmetabolism as well as the antioxidant capacity ([@bib22]; [@bib53], [@bib54]).

Modern medicine is getting personalized and machine learning algorithms are increasingly used to predict the success of therapeutic interventions based on patient individual characteristics. This was the case for the prediction of postprandial lipemic and inflammatory responses ([@bib8]), the development gestational diabetes ([@bib4]), or even the occurrence of heart attacks and stroke ([@bib30]). Earlier studies also suggest that this can be applicable to understand redox systems as a recent study successfully developed a neural network to predict oxidative damage using measurements of antioxidants in plasma and urine ([@bib19]).

Since dysmetabolism has been repeatedly correlated to an increased oxidative stress (A [@bib46]; [@bib25]; [@bib43]), it can be hypothesized that beneficial effects of long-term fasting could be affected by the baseline antioxidant status of patients. The BDNF, which has its production stimulated by ketosis during fasting ([@bib33]), is known to control the nuclear translocation of the transcription factor Nrf2 to activate antioxidant defenses ([@bib11]). Furthermore, the mild oxidative stress caused by the reduction in adenosine triphosphate (ATP)/adenosine monophosphate (AMP) ratio has a similar effect to activate transcription of cytoprotective enzymes sulfiredoxin 1, thioredoxin reductase 1, heme oxygenase-1, as well as several others conjugation and elimination enzymes ([@bib13]).

This article is a continuation of our previous study on the effect of a 10-day fasting on indicators of redox status of humans which showed that while the total antioxidant capacity (TAC) was enhanced, TBARS, an important indicator of lipid peroxidation, were reduced ([@bib54]). The aim of the present article was to analyze additional redox parameters and to correlate the redox status with markers of glucose and lipid status, the improvement of which leads to a better metabolic health and a reduced risk of metabolic diseases. It was also evaluated if the baseline levels in markers of the redox status can predict the success of the fasting regimen using a machine learning approach.

2. Materials and methods {#sec2}
========================

2.1. Ethics statement {#sec2.1}
---------------------

This interventional study was approved by the medical council of Baden-Württemberg, Stuttgart, on 12 February 2019 under the application number F-2018-118. The study protocol was implemented in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) and registered on 20 February 2019 in the German Clinical Trials Register (DRKS-ID: DRKS00016657). The recruitment was conducted between 15 September 2019 and 18 november 2019. All participants gave their written informed consent before enrolling into the study.

2.2. Participants {#sec2.2}
-----------------

The 109 study participants were recruited out of a total of 182 subjects who were admitted to the Buchinger Wilhelmi Clinic (BWC) and fulfilled the following criteria: Subjects were aged between 18 and 70 years and underwent at least 7 to maximum 13 (10 ± 3 days) days of fasting. Two blood samplings at the beginning and at the end of the experiment were conducted. One week prior as well as during the fasting period the intake of micronutrient supplements was advised to be stopped, except for magnesium supplementation. Clinical experience showed that magnesium intake during the fasting course seems to protect against muscle cramps that possibly could be provoked by the recommendation to drink sufficient liquids during fasting. Subjects were excluded when they had a predefined contraindication to fasting as described in the guidelines of fasting therapy ([@bib52]) like cachexia, anorexia nervosa, advanced kidney, liver or cerebrovascular insufficiency, dementia or other chronic psychiatric diseases, as well as pregnant or lactating women. Furthermore, subjects who could not follow the study procedure due to an inability to speak German, English or French, or subjects that were participating in another study, were also excluded. Altogether, 37 subjects did not meet the inclusion criteria, and 35 subjects declined to participate. One subject terminated the study earlier as defined in the protocol due to low hemoglobin and sodium levels.

2.3. The fasting protocol {#sec2.3}
-------------------------

All subjects underwent a medical supervised fasting program according to peer-reviewed guidelines ([@bib52]) that included physical exercise and individual treatments ([@bib53]). On the day prior fasting the subjects received a 600 kcal diet of either rice and vegetables or fruits. To initiate the fasting period, a laxative (20--40 g Na~2~SO~4~ in 500 ml water) was administered. During fasting, an enema was applied every other day to remove intestinal remnants and desquamated mucosal cells. A calorie intake of \~250 kcal/day was ensured by the daily intake of 250 ml freshly squeezed organic juice at midday, and 250 ml of vegetable soup in the evening, as well as 20 g honey per day. The subjects were advised to drink daily at least 2--3 L of water or non-caloric herbal teas. A stepwise reintroduction of food with an ovo-lacto-vegetarian organic diet from 800 to 1600 kcal/day followed the fasting period.

2.4. Clinical data {#sec2.4}
------------------

Clinical data were collected according to the BWC standards. Before start of the fasting program, the subjects underwent a thorough physical examination. Measurements were performed at two time-points in the morning in the fasted state. The baseline examination was conducted before starting of the fast (time point \#1, pre) and the second examination was done at the 10 ± 3 fasting day (time-point \#2, post). Subjects' height was measured with seca 285 (Seca, Hamburg, Germany) and the waist circumference was assessed with a measuring tape, placed halfway between the lowest rib and the iliac crest. Body weight was measured daily (Seca 704/635, Seca, Hamburg, Germany) between 7:00 am and 9:00 am by trained nurses, while subjects were lightly dressed. Additionally, blood pressure and heart rate were measured on the non-dominant arm after a rest, while subjects were seated (boso Carat professional; BOSCH + SOHN GmbH u. Co. KG).

Subjects self-reported their energy level on a numeric rating scale from 0 (weak) to 10 (powerful) before and after fasting. Furthermore, the well-being index (WHO-5) was self-assed by answering five statements scored from 0 (at no time) to 5 (all of the time). After building the sum of the five scores and multiplying it with 4 the WHO-5 was given as a percentage between 0% and 100% ([@bib6]). Possible adverse events were documented in a report form by the medical staff.

2.5. Blood collection and handling for the measurement of redox biomarkers {#sec2.5}
--------------------------------------------------------------------------

Blood samples were collected twice, at baseline in the first morning after arrival and at the 10 ± 3 fasting day by trained medical-technical assistants between 7.30 and 9.00 am Blood samples (10 ml) were drawn from a forearm vein with subjects sitting in an upright position. Blood was collected in ethylenediaminetetraacetic acid (EDTA) tubes, centrifuged immediately (1370 g, 10 min, 4 °C), and the plasma was collected and used for the measurement of the ABTS radicalscavenging activity, the reducing power, the hydroxyl radical (OH^∙^ ^-^) scavenging activity, the superoxide anion (O2^∙-^) radical-scavenging ability of plasma and the protein carbonyls an index of protein oxidation. The remaining packed erythrocytes were lysed with dH~2~O (1:1 v/v), inverted vigorously, centrifuged (4020 g, 15 min, 4 °C) and the erythrocyte lysate was collected for the measurement of Superoxide Dismutase (SOD) activity. Plasma and erythrocyte lysate samples were then stored at −80 °C until the biochemical analyses were performed.

Routine laboratory blood parameters were performed in the laboratory MVZ Labor Ravensburg. The lipid parameters (total cholesterol, LDL, HDL, triglycerides), glucose, liver enzymes (serum glutamic oxaloacetic transaminase (GOT), serum glutamate pyruvate transaminase (GPT), serum gamma-glutamyl transferase (GGT), alkaline phosphatase (AP)), and kidney parameters (glomerular filtration rate (GFR), urea, creatinine, uric acid), as well as the inflammatory parameter C-reactive protein (CRP) were analyzed with ADVIA 2400 (Siemens Health care GmbH, Erlangen, Germany). Insulin was measured with Centaur XP (Siemens Healthcare GmbH) and HbA1c was assessed with TOSOHTM (Bio-Rad Laboratories GmbH, München, Germany).

2.6. Protocols for the measurement of redox biomarkers {#sec2.6}
------------------------------------------------------

The concentration of protein carbonyls, an index of protein oxidation, was determined based on the method described in the study by [@bib41]. In this assay, 50 μl of 20% TCA were added to 50 μl of plasma and this mixture was incubated in an ice bath for 15 min and centrifuged at 15,000×*g* for 5 min at 4 °C. The supernatant was discarded and 500 μl of 10 mM 2,4-dinitrophenylhydrazine (DNPH; Sigma-Aldrich, Munich, Germany) (in 2.5 N HCl) for the sample, or 500 μl of 2.5 N HCl for the blank, were added to the pellet. The samples were incubated in the dark at room temperature for 1 h with intermittent vortexing every 15 min and were centrifuged at 15,000×*g* for 5 min at 4 °C. The supernatant was discarded and 1 ml of 10% TCA was added, vortexed and centrifuged at 15,000×*g* for 5 min at 4 °C. The supernatant was discarded and 1 ml of ethanol-ethyl acetate (1:1 v/v) was added, vortexed and centrifuged at 15,000×*g* for 5 min at 4 °C. This washing step was repeated twice. The supernatant was discarded and 1 ml of 5 M urea (pH = 2.3) was added, vortexed and incubated at 37 °C for 15 min. The samples were centrifuged at 15,000×*g* for 3 min at 4 °C and the absorbance was read at 375 nm. The calculation of the protein carbonyls concentration was based on the molar extinction coefficient of DNPH. Total plasma protein was assayed using the Bradford protein assay.

The superoxide anion radical-scavenging ability of plasma was measured using a slightly modified protocol of [@bib2]. In this method, superoxide anion (O~2~ ^∙−^) is generated in a phenazine methosulfate and reduced nicotinamide adenine dinucleotide (PMS-NADH) system by NADH oxidation and it reduces the yellow dye of nitroblue tetrazolium (NBT~2~ ^+^) to the blue colored formazan. More specifically, 125 μl of 300 μM NBT~2~ ^+^, 125 μl of 468 μM NADH, and 10 μl of deproteinaized plasma were added into 625 μl of 16 mM Tris-HCl (pH = 8.0). The reaction is initiated by the addition of 125 μl of 60 μM PMS to the mixture. The samples were incubated for 5 min and the absorbance was monitored at 560 nm. Plasma antioxidants are acting as inhibitors to the blue colored formazan formation.

In the reducing power assay, a plasma sample was dissolved in phosphate buffer (0.2 M, pH = 6.6) at different concentrations. An aliquot (10 μl) of the sample solution was added to 490 μl of 1% potassium ferricyanide and incubated at 50 °C for 20 min. The samples were cooled on ice for 5 min. Then, 250 μl of 10% TCA was added and the samples were centrifuged (1700 g, 10 min, and 25 °C). Subsequently, 250 μl of dH~2~O and 50 μl of 0.1% ferric chloride were added to the supernatant and the samples were incubated at RT for 10 min. The absorbance was monitored at 700 nm ([@bib59]).

Regarding the assay for hydroxyl radical (OH^∙^ ^-^) scavenging activity, 10 μl of plasma dissolved in dH~2~O at different concentrations was added to 450 μl of 0.2 M sodium phosphate buffer (pH = 7.4), 150 μl of 10 mM 2-deoxyribose, 150 μl of 10 mM FeSO~4~-EDTA, 525 μl of dH~2~O, and 150 μl of 10 mM H~2~O~2~. Then, the samples were incubated at 37 °C for 4 h. Afterwards, 750 μl of 2.8% TCA and 750 μl of 1% TBA were added, and the samples were incubated at 95 °C for 10 min. Then, the samples were cooled on ice for 5 min, centrifuged (1700 g, 10 min, and 25 °C), and the absorbance was monitored at 520 nm. In each experiment, the sample without H~2~O~2~ was considered as blank and the sample without protein as control ([@bib16]).

The free radical-scavenging activity of the samples was also determined by ABTS radical cation (ABTS^•+^) decolorization assay as previously described by [@bib14], with some modifications. In brief, ABTS^•+^ radical was produced by mixing 2 mM ABTS with 30 μM H~2~O~2~ and 6 μM horseradish peroxidase (HRP) enzyme in 50 mM PBS (pH = 7.5). Immediately, following the addition of the HRP enzyme, the contents were vigorously mixed, incubated at room temperature in the dark and the reaction was monitored at 730 nm until stable absorbance was obtained. Subsequently, 10 μl of plasma were added in the reaction mixture and the decrease in absorbance at 730 nm was measured. In each experiment, the tested sample alone containing 1 mM ABTS and 30 μM H~2~O~2~ in 50 mM PBS (pH = 7.5) was used as a blank, while the formed ABTS^•+^ radical solution alone with 10 μl H~2~O was used as a control.

The determination of SOD activity in RBCL was based on the method of nitroblue tetrazolium salt (NBT) as described in the study by [@bib38]. More specifically, this assay included a negative control which was prepared by mixing 800 μl of SOD buffer \[1 mM diethylenetriaminepentaacetic acid (DETAPAC) in 0.05 M potassium phosphate buffer (pH = 7.8), 1 unit CAT, 5.6 × 10^−5^ M NBT and 10^−4^ M xanthine\] with 200 μl of 0.05 M potassium phosphate buffer. Subsequently, \~60 mU of xanthine oxidase were added and the rate of increase in absorbance was measured at 560 nm for 1.5 min. In the test samples, 200 μl of the total 1:100 RBCL were added to 800 μl of SOD buffer followed by the addition of \~60 mU of xanthine oxidase and the rate of increase in absorbance was measured for 1.5 min at 560 nm. The calculation of SOD activity in the test samples is based on the percentage inhibition in the rate of increase in absorbance. SOD activity in the RBCL was normalized to the total cellular Hb level in each sample. The results are expressed as units (one unit of SOD inhibits the rate of increase in absorbance at 550 nm by 50%) per mg of Hb.

Previously published data were reanalyzed in order to obtain a comprehensive evaluation of the redox status. The measurement of glutathione (GSH) levels, catalase activity, TAC, TBARS, Glutathione Peroxidase (GPx) and Glutathione reductase (GR) activities were performed as previously described ([@bib54]). In brief, GSH levels were measured according to Reddy et al. as previously descrided by [@bib51]. The intra- and inter-assay CVs for GSH were 3.1% and 4.5%, respectively. For catalase activity, the method of Aebi was used ([@bib1]). The intra- and inter-assay CVs for catalase were 6.2% and 10.0%, respectively. The determination of TAC was based on the method of Janaszewska and Bartosz as mmol of DPPH^•^ reduced to 2, 2-diphenyl-1-picrylhydrazine (DPPH:H) by the antioxidants of plasma ([@bib26]). The intra- and inter-assay CVs for TAC were 2.9% and 5.4%, respectively. For TBARS determination, a slightly modified assay of Keles et al. was used ([@bib28]). The intra- and inter-assay coefficients of variation (CV) for TBARS were 3.9% and 5.9%, respectively. GPx activity was measured according to Flohe and Gunzler, and calculated based on the molar extinction coefficient of NADPH (6200 L/mol/cm) as previously described by [@bib51]. Finally, GR activity was measured according to a protocol from Tietze et al., which was modified by Smith et al. and described previously by [@bib51].

2.7. Statistical analysis {#sec2.7}
-------------------------

The statistical analysis was performed using R version 4.0.0. The correlations were studied using the Pearson correlation coefficient. Pair-wise comparisons were performed using a paired *t*-test. Associations between the different clinical parameters were evaluated using linear mixed models (R package lmerTest), considering the time point as a covariate and the repeated measure (patient grouping) as a random effect. Likelihood Ratio Tests were performed to evaluate the significance of the effects. Data was visualized using the R package ggplot2.

Marker of the redox status were used to predict the amplitude of metabolic changes with the caret package (Classification And REgression Training) in R on a training set constituting 60% of the patients. Missing values were imputed as column medians with randomForest:: na.roughfix(). Variables in the training sets were scaled and centered before a linear model was used to evaluate which are the most important predictors of the weight loss and the LDL level decrease with the function caret::train(). The machine learning model was then tested on the remaining (40%) patients. Its performance was evaluated by correlating the predicted outcomes with the actual outcomes with a correlation test.

3. Results {#sec3}
==========

The aim of this study was to understand the interplay between markers of the redox status and the metabolic changes observed during a long-term fasting in 109 individuals. For this purpose, 12 markers of the redox status were evaluated ([Fig. 1](#fig1){ref-type="fig"} ). This included markers of oxidative stress/damage (TBARS, carbonyls), as well as markers of the antioxidant capacity (GSH, TAC, superoxide scavenging capacity, reducing power, hydroxyl radical scavenging capacity, ABTS^•+^ radical scavenging capacity, as well as GPx, SOD and GR activities). The mean age of the study population was 57 years and 62% of the participants were female ([Table 1](#tbl1){ref-type="table"} ). The cohort was predominantly overweight with an initial BMI of 28.34 ± 6.01 kg/m^2^, and waist circumference of 95.8 ± 14.2 cm. Baseline metabolic parameters like blood glucose, insulin, total cholesterol and triglycerides reflected a generally healthy study population ([Supplementary Table 1](#appsec1){ref-type="sec"}).Fig. 1Overview of the measured redox parameters.Fig. 1Table 1Demographic characteristics of the cohort. Statistical differences between the repeated-measures comparison was determined using a paired *t*-test.Table 1ParametersBaselineAge, years57.0 (±10.5)Female, n68 (62%)Male, n41 (38%)

Analysis of correlations between the redox status and clinical parameters confirmed the link between markers of metabolic health and the antioxidant status established in our first study ([@bib54], [@bib55]). The strongest correlation observed was between uric acid levels and the TAC ([Fig. 2](#fig2){ref-type="fig"} ). Although most of the parameters reflecting the antioxidant capacity were poorly correlated to markers of metabolic health, there was a clear correlation between the markers of oxidative damages to lipids which had their levels the highest in individuals with a poor metabolic heath. This was reflected by the positive correlation of TBARS levels with waist circumference, BMI, glucose, GPT, GOT, GGT and triglyceride ([Fig. 2](#fig2){ref-type="fig"}).Fig. 2Redox parameters correlate with metabolic parameters before fasting. The heatmap displays the correlations between the redox parameters (rows) and the metabolic parameters (columns). Dendrograms shows the relationships between the different parameters evaluated using the hierarchical clustering of Euclidean distance. The colour scale shows the coefficient of correlations. Statistical significance was tested (\*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001).Fig. 2

The present results confirm the improvement in lipid ([Fig. 3](#fig3){ref-type="fig"} A to E) and glucose ([Fig. 3](#fig3){ref-type="fig"}F and G) metabolism which were evidenced in a larger cohort ([@bib53]), and show that these metabolic improvements are reproducible. In addition, well-being improvements were confirmed with new methods (i.e. energy levels, [Fig. 3](#fig3){ref-type="fig"}H; WHO-5 index, [Fig. 3](#fig3){ref-type="fig"}I). Next, the changes in 12 biomarkers of antioxidant systems caused by long-term fasting were studied ([Fig. 3](#fig3){ref-type="fig"}J to U). Gender differences were limited to TBARS levels which were higher at baselines in males. Gender did not have a substantial effect on the effects of fasting on redox parameters. Glutathione levels ([Fig. 3](#fig3){ref-type="fig"}J) and its regulation through GR ([Fig. 3](#fig3){ref-type="fig"}M) and GPx activities ([Fig. 3](#fig3){ref-type="fig"}N) were unchanged. However, the antioxidant capacity reflected by the TAC ([Fig. 3](#fig3){ref-type="fig"}L) and the reducing power ([Fig. 3](#fig3){ref-type="fig"}U) were increased. This ultimately increased ROS scavenging potential as showed by an increase hydroxyl radical scavenging activity ([Fig. 3](#fig3){ref-type="fig"}R) and an increased ABTS scavenging ([Fig. 3](#fig3){ref-type="fig"}S). This improvement of the antioxidant capacity was concomitant to a decrease in markers of oxidative stress/damage TBARS ([Fig. 3](#fig3){ref-type="fig"}T).Fig. 3The effects of the 10-day fast in a group of 109 subjects. Individuals variations are presented along with summary statistics for the markers of lipid metabolism (A--E), glucoregulation (F--G), well-being (H--I), as well as for the 12 biomarkers of the redox status (J--U) measured before (pre) and after 10 ± 3 days (post) of a long-term fasting (red, females; blue, males).Fig. 3

Since substantial changes in energy metabolism occurred during fasting, it was evaluated if the changes in antioxidant status interacted with the changes in markers of metabolic health caused by fasting. This was done by associating the levels of redox parameters with the metabolic responses. The strongest interactions were between markers of lipid peroxidation and lipid levels. Lipid peroxidation levels affected the effects of fasting on the normalization of lipid levels ([Fig. 4](#fig4){ref-type="fig"} ). When lipid peroxidation is high, patients are most resistant to the normalization effect of fasting (interaction p-values 8.2e-06 and 4.1e-05 for LDL and cholesterol, respectively). This remained significant if the significance cut-off threshold was corrected by the number of comparisons (α = 0.0002). Estimate coefficients from this model suggested that LDL levels would decrease from 4.2 to 2.3 mmol/L for an hypothetical patient with no lipid peroxidation, and that every increase in lipid peroxidation by 1 μmol/L of TBARS would decrease the reduction in LDL levels by 0.25 mmol/L. The inclusion of BMI as a covariate did not change the result of this analysis, and a likelihood ratio test between a full model containing BMI as a covariate and its null model (no BMI added) was not statistically significant. It is reasonable to assume that the decreased in lipid levels caused by their use as energy substrates during fasting could be linked to the decreased lipid peroxidation. If lipid concentrations decrease, they are less available and lipid peroxidation levels decrease in return.Fig. 4Lipid peroxidation levels affects the effects of long-term fasting on the normalization of lipid levels. A linear mixed model showed that LDL and TBARS levels interact with the effects of fasting on the change in lipid levels.Fig. 4

Ultimately, a machine learning algorithm was trained to predict the beneficial effects of long-term fasting from the redox status before the patients start the fast. Lipid peroxidation was the most important predictor of the changes in LDL levels on the training set made of 60% of the individuals ([Fig. 5](#fig5){ref-type="fig"} ), confirming the results of the linear mixed models ([Fig. 4](#fig4){ref-type="fig"}). The model was validated on an independent test set consisting of 44 patients (40% of the data), with a statistically significant correlation between the predicted LDL decrease and the actual LDL decrease (p = 0.016). It was also evaluated if metabolic parameters at baseline (described in [Fig. 2](#fig2){ref-type="fig"}) could predict the changes in lipid peroxidation during fasting but failed to establish a model with good predictive abilities.Fig. 5A machine learning algorithm using a combination of antioxidant parameters measured at baseline can predict changes in markers of metabolic health caused by long-term fasting. The left panel shows which redox parameters contributes to the predictive ability of the model. On the right hand side, it is shown that the values predicted by the model on an independent test set correlate well with the measured decrease in LDL during fasting.Fig. 5

Although the predictive ability of the redox status to predict metabolic changes caused by long-term fasting will have to be confirmed on a new cohort, and with more patients, the remarkable performance of this model considering the relatively small number of patients suggest that the antioxidant status is a crucial determinant of the normalization of lipid levels during long-term fasting. Collectively, the results show that the effects of long-term fasting on lipid metabolism are influenced by the redox status, and that these effects can be predictable by the levels of redox parameters before fasting using machine learning approaches.

4. Discussion {#sec4}
=============

There is growing need of therapeutic strategies to increase the antioxidant defense mechanisms against infectious diseases like covid-19 and to improve simultaneously the metabolic health status. In the present study we expanded the insight about the effects of a 10-day fasting period on blood redox markers: Beyond the previously identified amelioration of the TAC and TBARS, it was demonstrated that indicators of the plasmatic antioxidant capacity like reducing power, ABTS radical scavenging capacity, and hydroxyl radical scavenging capacity increased significantly, which indicates an increase of the circulating antioxidant levels.

Redox changes were concomitant to a reduction in body weight and visceral fat, as well as an improvement in markers of glucose and lipid metabolism. Comparable effects were described after intermittent fasting in laboratory animals ([@bib24]; [@bib56], [@bib57]) and human populations ([@bib48]; [@bib49]). Energy levels and well-being index increased documenting the tolerability of this fasting program. This might be attributable to hormonal changes caused by fasting ([@bib39]), or to the mood enhancing effects of ketosis ([@bib33]), but also to the healthy lifestyle associated with the stay at the clinic (medical care and improved well-being). In addition, the decreased body weight ([@bib40]), and increased physical exercise ([@bib44]), can also increase well-being. Biochemical factors including blood glucose, HbA1c, insulin, triglycerides, total cholesterol, LDL, and HDL were lowered and total cholesterol/HDL was enhanced which in combination with the aforementioned markers, create a more favorable metabolic environment ([@bib54]). This also showed that the effects described in a larger cohort in 2016 are reproducible ([@bib53]).

It was demonstrated that long-term fasting can increase the endogenous production of a number of antioxidant molecules that act protectively against free radicals. These findings are in contrast to the preconceived idea that the antioxidant reserves would decrease during fasting due to a lack of absorbed micronutrients with known antioxidative roles (e.g. vitamin E and B, zinc, selenium) after the cessation of food intake. When exogenous antioxidants are missing, endogenous antioxidants are sufficient to maintain homeostasis. This includes uric acid and bilirubin, two important endogenous antioxidants ([@bib3]; [@bib45]). Although bilirubin was not measured in this study, we measured the increase in uric acid and its association with TAC, that was discussed in detail in the previous article ([@bib54]). It is worth mentioning again that high uric acid levels are well-known in long-term fasting and only exceptionally lead to side-effects as long as fasting individuals drink enough water ([@bib53]). Eight-weeks intermittent fasting confirmed the increase in uric acid levels in asthmatic patients and found a reduction in oxidative stress markers like 8-prostane, nitrotyrosine, protein carbonyls and 4-hydroxynonenal adducts ([@bib27]). Bilirubin levels have been extensively studied in previous studies and, in particular, it has been observed that 48-h fasting can increase those levels by 240% while 62-h fasting by 326% ([@bib5]; [@bib21]; [@bib35]). It is hypothesized that organisms with protective redox systems have been selected in the course of evolution to provide protection against ROS caused aging and cancer ([@bib3]), It is plausible that resilient organisms which were able to maintain antioxidative functions during periods of famine through endogenous antioxidant production were selected in the same way.

In the aforementioned methods for determining the antioxidant capacity of plasma, the various antioxidant molecules participate in different ways due to their physicochemical characteristics ([@bib7]; [@bib26]). As uric acid is involved differently in these methods, it can affect differently the levels of the determined antioxidant capacity. Something similar happens with bilirubin and other antioxidant molecules that are affected by fasting.

Besides showing that long-term fasting improves the redox status and metabolic health indicators, an interplay between these parameters was described. The strongest correlation observed was between uric acid levels and the TAC, which was expected, since much of the TAC is due to the circulating uric acid ([@bib26]). However, the most important biological correlation was observed between TBARS and lipid metabolism. In general, TBARS decreased significantly after long-term fasting, as did total cholesterol, LDL and triglyceride levels, with a parallel decrease in waist circumference and BMI. Higher lipid peroxidation levels at baseline, reduced the ability of long-term fasting to normalize dyslipidemia.

Our machine learning algorithm confirmed that the levels of TBARS is a reliable predictor of how well a person will respond to long-term fasting. This model was trained and evaluated on a modest sample size. Future studies would have to be done to test if the predictive ability of TBARS levels can be replicated in a different group of individuals, ideally larger in order to better understand the influence of demographic covariates (age, sex, diseases). Our results suggest that analyzing the antioxidative status before fasting could help to enhance the efficiency of the fasting regimen by preparing the patients with the poorest metabolic status through boosting their antioxidant status in a personalized and adapted way. In general, dietary guidelines are provided for an average population ([@bib23]) and do not account for inter-individual differences. However, an increasing number of studies are showing that response to diet is personal and that these differences can affect disease susceptibility ([@bib60]). This can be due to differences in lifestyle, genetics, or even gut microbiome composition ([@bib8]). We suggest in this study that the response to fasting can also be individual and showed that it can depend on the baseline antioxidative status. Factors driving these differences would have to be evaluated in further studies including measurement of gut microbiome composition, as it was repeatedly showed to be an important factor driving personal susceptibility to disease ([@bib50]). In addition, it was also shown that the gut microbiome dramatically changed during fasting, and were correlated to changes in energy metabolism ([@bib34]).

Since lipids are used as energy substrates during fasting, it is reasonable to assume that the decrease in lipid levels, could partly lead to decreased lipid peroxidation. We documented in an unpublished study that the more atherogenic, small dense LDL particles diminished significantly after 14 fasting days. Since they are the most oxidizable, it seems logical that the lipid peroxidation levels decrease ([@bib15]). Furthermore, HDL is the greatest antagonist of lipid oxidation and it was documented that total cholesterol/HDL increased significantly during long-term fasting ([@bib12]).

5. Conclusions {#sec5}
==============

The results of our study conclude that fasting improves oxidative stress indicators by increasing the antioxidant capacity of the blood plasma through the increase in TAC, reducing power, ABTS radical scavenging capacity and hydroxyl radical scavenging capacity. At the same time, fasting reduces lipid peroxidation and improves various metabolic indicators, especially lipids. Furthermore, total cholesterol/HDL improved significantly. Although the prognostic ability of the redox status to predict metabolic changes caused by long-term fasting will have to be confirmed on a larger cohort, the remarkable performance of this model considering the relatively small number of patients suggest that the antioxidant status is a crucial determinant of the normalization of lipid levels during long-term fasting.

Altogether, our results show that the effects of long-term fasting on lipid metabolism are influenced by the redox status, and that these effects can be forecasted based on the levels of redox parameters before fasting through the use of machine learning approaches. We recommend that long-term fasting strategies should be personalized and adjusted to the metabolic and antioxidative baseline status of the subjects.
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